2,461 reports of this reaction
10.9% of all ALTEPLASE reports
#1 most reported adverse reaction
NO ADVERSE EVENT is the #1 most commonly reported adverse reaction for ALTEPLASE, manufactured by Genentech, Inc.. There are 2,461 FDA adverse event reports linking ALTEPLASE to NO ADVERSE EVENT. This represents approximately 10.9% of all 22,483 adverse event reports for this drug.
Patients taking ALTEPLASE who experience no adverse event should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NO ADVERSE EVENT is a frequently reported adverse event for ALTEPLASE, accounting for a significant proportion of all reports.
In addition to no adverse event, the following adverse reactions have been reported for ALTEPLASE:
The following drugs have also been linked to no adverse event in FDA adverse event reports:
NO ADVERSE EVENT has been reported as an adverse event in 2,461 FDA reports for ALTEPLASE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NO ADVERSE EVENT accounts for approximately 10.9% of all adverse event reports for ALTEPLASE, making it one of the most commonly reported side effect.
If you experience no adverse event while taking ALTEPLASE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.